A common immunotherapy approach helped stave off disease progression in patients with a form of anal cancer that is caused by ...

BARCELONA, Spain — Adding a second immunotherapy from Bristol Myers Squibb to an existing checkpoint inhibitor and ...

Pfizer reported at #ESMO that an experimental antibody helped cancer patients with a condition known as cachexia.

A targeted immunotherapy being developed by iTeos Therapeutics and GSK, it was reported at #ESMO, delivered promising ...